001438093 000__ 05083cam\a2200601\i\4500
001438093 001__ 1438093
001438093 003__ OCoLC
001438093 005__ 20230309004247.0
001438093 006__ m\\\\\o\\d\\\\\\\\
001438093 007__ cr\un\nnnunnun
001438093 008__ 210716s2021\\\\sz\a\\\\ob\\\\001\0\eng\d
001438093 019__ $$a1261364719$$a1266812257$$a1294400452
001438093 020__ $$a9783030735036$$q(electronic bk.)
001438093 020__ $$a3030735036$$q(electronic bk.)
001438093 020__ $$z9783030735029
001438093 020__ $$z3030735028
001438093 0247_ $$a10.1007/978-3-030-73503-6$$2doi
001438093 035__ $$aSP(OCoLC)1260291519
001438093 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCO$$dOCLCF$$dDCT$$dSFB$$dUKAHL$$dOCLCO$$dN$T$$dOCLCQ$$dCOM$$dOCLCO$$dOCLCQ
001438093 049__ $$aISEA
001438093 050_4 $$aRC347.5$$b.J35 2021
001438093 08204 $$a616.8/0471$$223
001438093 1001_ $$aJain, K. K.$$q(Kewal K.),$$eauthor.
001438093 24510 $$aDrug-induced neurological disorders /$$cKewal K. Jain.
001438093 250__ $$aFourth edition.
001438093 264_1 $$aCham :$$bSpringer,$$c[2021]
001438093 264_4 $$c©2021
001438093 300__ $$a1 online resource :$$billustrations
001438093 336__ $$atext$$btxt$$2rdacontent
001438093 337__ $$acomputer$$bc$$2rdamedia
001438093 338__ $$aonline resource$$bcr$$2rdacarrier
001438093 347__ $$atext file
001438093 347__ $$bPDF
001438093 504__ $$aIncludes bibliographical references and index.
001438093 5050_ $$a1. Introduction, history and epidemiology of drug-induced neurological disorders -- 2. Neurologic symptoms as adverse drug reactions -- 3. Role of the blood-brain barrier in effects of drugs on the brain -- 4. Pathomechanisms of drug-induced neurological disorders -- 5. Adverse effects of drugs on the fetal nervous system -- 6. Principles of management of drug-induced neurological disorders -- 7. Methods of drug delivery to the nervous system and DIND -- 8. Neurological complications of anesthesia -- 9. Neurological complications of cancer therapies -- 10. Adverse effects of biological therapies on the nervous system -- 11.Drug-induced aseptic meningitis -- 12. Drug-induced intracranial hypertension -- 13. Drug-induced encephalopathies -- 14. Drug-induced disorders of memory and dementia -- 15. Drug-induced disturbances of consciousness -- 16. Drug-induced neuro-psychiatric disorders -- 17. Neurological effects of drug abuse -- 18. Drug-induced sleep disorders -- 19. Drug-induced seizures -- 20. Drug-induced movement disorders -- 21. Tardive dyskinesia -- 22. Drug-induced headaches -- 23. Drug-induced cerebrovascular disorders -- 24. Drug-induced disorders of cranial nerves -- 25. Drug-induced neurootological disorders -- 26. Drug-induced neuro-ophthalmological disorders -- 27. Drug-induced disorders of smell and taste -- 28. Drug-induced peripheral neuropathies -- 29. Drug-induced disorders of the autonomic nervous system -- 30. Drug-induced neuromuscular disorders -- 31. Drug-induced myopathies -- 32. Drug-induced spinal disorders -- 33. Drug-induced cerebellar disorders -- 34. Eosinophilia-myalgia syndrome -- 35. Drug-induced pituitary disorders -- 36. Serotonin syndrome -- 37. Drug-induced Guillain-Barré syndrome -- 38. Neuroleptic malignant syndrome.
001438093 506__ $$aAccess limited to authorized users.
001438093 520__ $$aThis book is a first-of-its kind reference that systematically organizes and describes the adverse effects of drugs on the nervous system. Drug safety is recognized as an important aspect of pharmaceutical companies as well as practice of medicine. Chapters include case reports of adverse effects of drugs that are published as well as reported to drug manufacturers. The book scope is broad as it covers lack of efficacy, drug resistance, drug-disease and drug-drug interactions. This information is used to improve the use of drugs as well as to design better and safer drugs for the future, and is relevant to personalized medicine in trying to match the right drugs to the patients. Drug-induced Neurological Disorders offers a unique approach to this important topic by integrating clinical neurology with pharmacology with a focus on effects of drugs on the nervous system including those used for the treatment of neurological disorders as well systemic diseases. Many adverse effects involve multiple systems of the body and the syndromes with predominant effect on the nervous system are included in this book.
001438093 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed July 27, 2021).
001438093 650_0 $$aNervous system$$xDiseases$$xEtiology.
001438093 650_0 $$aNeuropharmacology.
001438093 650_0 $$aDrugs$$xSide effects.
001438093 650_6 $$aSystème nerveux$$xMaladies$$xÉtiologie.
001438093 650_6 $$aNeuropharmacologie.
001438093 650_6 $$aMédicaments$$xEffets secondaires.
001438093 655_7 $$aLlibres electrònics.$$2thub
001438093 655_0 $$aElectronic books.
001438093 77608 $$iPrint version:$$aJain, K. K. (Kewal K.).$$tDrug-induced neurological disorders.$$bFourth edition.$$dCham : Springer, [2021]$$z3030735028$$z9783030735029$$w(OCoLC)1241245324
001438093 852__ $$bebk
001438093 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-73503-6$$zOnline Access$$91397441.1
001438093 909CO $$ooai:library.usi.edu:1438093$$pGLOBAL_SET
001438093 980__ $$aBIB
001438093 980__ $$aEBOOK
001438093 982__ $$aEbook
001438093 983__ $$aOnline
001438093 994__ $$a92$$bISE